Company Info
Phone(617) 865-9628
Year Established
2021
Ticker
ODTX
Exchange
NASDAQ
Contacts
Gary D. Glick, Ph.D.Co-Founder, President & CEO
Collin Todd
VP, Strategy & Business Development
Company Description
Odyssey is pioneering next generation precision immunomodulators and oncology medicines for patients through our industry leading discovery engine.